000 | 00820nam a2200241Ia 4500 | ||
---|---|---|---|
008 | 170220s9999||||xx |||||||||||||| ||und|| | ||
020 | _a978-94-017-7215-0 | ||
022 | _a2214-8019 | ||
040 | _aNISER LIBRARY | ||
041 | _aEnglish/International | ||
100 | _aRoberto Scatena | ||
245 | _aAdvances in Cancer Biomarkers | ||
250 | _a1st ed. 2015 | ||
260 |
_c2015 _bSpringer Netherlands |
||
300 | _bContributed volume | ||
440 |
_aAdvances in Experimental Medicine and Biology _n867 |
||
650 | _aBiomedical and Life Sciences | ||
650 | _aCancer Research; Oncology; Pharmacology/Toxicology | ||
710 | _aSpringer Science+Business Media Dordrecht | ||
856 | _uhttp://dx.doi.org/10.1007/978-94-017-7215-0 | ||
856 | _uhttp://link.springer.com/openurl?genre=book&isbn=978-94-017-7214-3 | ||
942 | _cEB | ||
999 |
_c28470 _d28470 |